SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Dornan T, Ashcroft D, Heathfield H, Lewis P, Miles J, Taylor D, Tully M, Wass V. An in depth investigation into causes of prescribing errors by foundation trainees in relation to their medical education – EQUIP study. 2009. Available at http://www.gmc-uk.org/about/research/research_commissioned_4.asp (last accessed 20 April 2011).
  • 2
    Leendertse AJ, Egberts ACG, Stoker LJ, van den Bemt PMLA, for the HARM Study Group. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008; 168: 18906.
  • 3
    Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR Pirmohamed P. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS ONE 2009; 4: e4439; doi:10.1371/journal.pone.000443.
  • 4
    British Pharmacological Society. Ten principles of good prescribing. Available at http://main.bps.ac.uk/SpringboardWebApp/userfiles/bps/file/Guidelines/BPSPrescribingPrinciples.pdf (last accessed 20 April 2011).
  • 5
    Gartner. eHealth for a healthier Europe! Available at http://www.regeringen.se/content/1/c6/12/98/02/5b63bacb.pdf (last accessed 20 April 2011).
  • 6
    Jha AK, Doolan D, Grandt D, Scott T, Bates DW. The use of health information technology in seven nations. Int J Med Inform 2008; 77: 84854.
  • 7
    Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change. Lancet 2003; 362: 11705.
  • 8
    Arguello B, Fernandez-Llimos F. Clinical pharmacology information in summaries of product characteristics and package inserts. Clin Pharmacol Ther 2007; 82: 56671.
  • 9
    Bergk V, Haefeli WE, Gasse C, Brenner H, Martin-Facklam M. Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature. Eur J Clin Pharmacol 2005; 61: 32735.
  • 10
    Martin-Facklam M, Rengelshausen J, Tayrouz Y, Ketabi-Kiyanvash N, Lindenmaier H, Schneider V, Bergk V, Haefeli WE. Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management? Eur J Clin Pharmacol 2005; 60: 80711.
  • 11
    Seidling HM, Storch CH, Bertsche T, Senger C, Kaltschmidt J, Walter-Sack I, Haefeli WE. Successful strategy to improve the specificity of electronic statin-drug interaction alerts. Eur J Clin Pharmacol 2009; 65: 114957.
  • 12
    Quinzler R, Gasse C, Schneider A, Kaufmann-Kolle P, Szecsenyi J, Haefeli WE. The frequency of inappropriate pill splitting in primary care. Eur J Clin Pharmacol 2006; 62: 106573.
  • 13
    Quinzler R, Szecsenyi J, Haefeli WE. Tablet splitting: patients and physicians need better support. Eur J Clin Pharmacol 2007; 63: 12034.
  • 14
    Koppel R, Metlay JP, Cohen A, Abaluck B, Localio AR, Kimmel SE, Strom BL. Role of computerized physician order entry systems in facilitating medication errors. JAMA 2005; 293: 1197203.
  • 15
    Strom BL, Schinnar R, Aberra F, Bilker W, Hennessy S, Leonard CE, Pifer E. Unintended effects of a computerized physician order entry nearly hard-stop alert to prevent a drug interaction: a randomized controlled trial. Arch Intern Med 2010; 170: 157883.
  • 16
    Horsky J, Kuperman GD, Patel VL. Comprehensive analysis of a medication dosing error related to CPOE. J Am Med Inform Assoc 2005; 12: 37782.
  • 17
    Bates DW. CPOE and clinical decision support in hospitals: getting the benefits. Arch Intern Med 2010; 170: 15834.
  • 18
    Eiermann B, Bastholm-Rahmner P, Korkmaz S, Lilja B, Veg A, Wettermark B, Gustafsson LL. Knowledge databases for clinical decision support in drug prescribing- development, quality assurance, management, integration, implementation and evaluation of clinical value. Chapyrt in Decision Support Systems, edited by Chiang S. Jao ISBN 978-953-7619-64-0, Vienna 2010.